Ovid Therapeutics Inc

Ovid Therapeutics Inc

OVID

Get informed when a big investor buys or sells

+ Follow
Market Cap$159.27M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Ovid Therapeutics IncOvid Therapeutics Inc-4.5--16%-0.1
$6.25

Target Price by Analysts

189.4% upsideOvid Therapeutics Target Price DetailsTarget Price
$-1.65

Current Fair Value

176.5% downside

Overvalued by 176.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$159.27 Million
Enterprise Value$160.66 Million
Dividend Yield$- (-)
Earnings per Share$-0.24
Beta0.23
Outstanding Shares73,735,606

Return

Return on Equity-16.43%ROE
Return on Assets-14.87%
Return on Invested Capital-26.45%

Valuation & Multiples

P/E Ratio-4.5P/E Ratio
PEG-2.04PEG
Price to Sales-Price to Sales
Price to Book Ratio1.08Price to Book Ratio
Enterprise Value to Revenue101.49
Enterprise Value to EBIT-2.74
Enterprise Value to Net Income-5
Total Debt to Enterprise0.08
Debt to Equity0.06Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 18, 2026
EPS Estimate
$-0.12
Average shareholder expectation
Revenue Estimate
$64,286
Average shareholder expectation

Next Earnings Call

Expected Date
November 11, 2026
EPS Estimate
$-0.08
Average shareholder expectation
Revenue Estimate
$31,091
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.6691▼ 95.66%
Total Calls139,300▲ 25.95%
Total Puts93,200▼ 48.16%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %199.97%▲ 57.48%
Total Invested$396.70M▲ 70.12%
Investors Holding135▲ 26.00%

ESG Score

No data

About Ovid Therapeutics Inc

CEO: Jeremy Levin